ABEC to supply China’s ‘rapidly growing’ biopharma industry from Ireland

ABEC-to-supply-China-s-rapidly-growing-biopharma-industry-from-Ireland.jpg
(Image: Getty/AlexLMX) (Getty Images/iStockphoto)

China has accredited ABEC to make and supply bioprocessing equipment from its Kells facility in Ireland.

The China Manufacture License (CML) recognises ABEC’s Kells facility, located in County Meath, as a qualified manufacturer of pressure vessels and bioprocessing components. The plant is ABEC’s second to receive a CML, after its Missouri facility was accredited in 2010.

“ABEC was awarded the CML for its Kells facility after a rigorous audit of its vessel engineering, manufacturing and quality processes by the China Special Equipment Inspection & Research Institute,” said ABEC CEO Scott Pickering in a statement.

According to ABEC spokesperson Susan Cooper-Curcio, many clients in China will benefit from the CML, including WuXi Biologics, which recently added ABEC’s 4,000L bioreactors to its fully single-use site.

“We also see the Kells CML benefiting clients from outside of China who are investing there,” she added.

ABEC’s custom single-use range famously ‘broke the 2,000L plastic ceiling’ in 2015 with its 4,300L bioreactor, and again in 2017 with its 4,900L system. 

This year, the firm has continued to invest in disposable technology, with an expansion of its Fermoy manufacturing facility in Ireland during February, and the addition of microbial fermentation capabilities to its single-use line in March.